U.S. markets closed
  • S&P 500

    3,785.38
    -33.45 (-0.88%)
     
  • Dow 30

    30,775.43
    -253.88 (-0.82%)
     
  • Nasdaq

    11,028.74
    -149.16 (-1.33%)
     
  • Russell 2000

    1,707.99
    -11.38 (-0.66%)
     
  • Crude Oil

    105.79
    +0.03 (+0.03%)
     
  • Gold

    1,806.90
    -0.40 (-0.02%)
     
  • Silver

    20.10
    -0.18 (-0.87%)
     
  • EUR/USD

    1.0479
    +0.0035 (+0.34%)
     
  • 10-Yr Bond

    2.9720
    -0.1210 (-3.91%)
     
  • GBP/USD

    1.2168
    +0.0046 (+0.38%)
     
  • USD/JPY

    135.7400
    -0.8050 (-0.59%)
     
  • BTC-USD

    18,873.27
    -1,317.52 (-6.53%)
     
  • CMC Crypto 200

    404.82
    -26.65 (-6.18%)
     
  • FTSE 100

    7,169.28
    -143.04 (-1.96%)
     
  • Nikkei 225

    26,393.04
    -411.56 (-1.54%)
     

The Worldwide Electronic Clinical Outcome Assessment Solutions Industry is Expected to Reach $4.12 Billion by 2030

·6 min read

DUBLIN, June 8, 2022 /PRNewswire/ -- The "Electronic Clinical Outcome Assessment Solutions Market Size, Share & Trends Analysis Report by Delivery Mode (Web & Cloud Based, On-premise), by End User, by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

Research_and_Markets_Logo
Research_and_Markets_Logo

The global electronic clinical outcome assessment solutions market size is anticipated to reach USD 4.12 billion by 2030. The market is expected to expand at a notable CAGR of 14.8% from 2022 to 2030.

The key factors driving the market growth include increasing interoperability across eClinical solutions, the surge in adoption owing to the COVID-19 pandemic, the use of telehealth, the need to comply with changing regulations, and the increasing complexity of data generated in clinical research.

The COVID-19 pandemic led to operational hurdles in clinical research activities including clinical trials. This included postponement of trials, recruitment challenges, and management problems. The pandemic, however, accelerated the adoption of enabling technologies for managing clinical trial operations and data. This boosted demand for eClinical solutions including electronic clinical outcome assessment (eCOA) solutions. As patients were unable to visit trial sites, eCOA solutions emerged as a reliable solution to collect patient data. It also helped sites maintain compliance during the pandemic. For instance, IQVIA reported that its eCOA platform was deployed multiple times during the pandemic in clinical trials.

The complexity in healthcare information management is anticipated to fuel the demand for eCOA solutions in the coming years. These solutions deliver accurate and timely health information and reduce the burden of patients enrolled in clinical trials. eCOA measures overall mental state, patient symptoms, and the progression of a disease. Electronic diaries and electronic Patient Reported Outcomes (ePRO) are a part of eCOA platforms. Electronic diaries help document patient responses. These are used as support systems for ePRO. eCOA solution from Cloudbyz for instance, includes ePRO and eDiary functionalities and supports electronic clinical outcome data capture with compliance adherence.

In addition, assessment systems help detect probable adverse conditions in advance for patients, which is crucial for taking preventive measures to avoid adverse effects in the future. The ePRO platforms transfer real-time data from the patients to healthcare professionals for accurate decision-making and better evaluation of a patient's health.

Thus, the adoption of these platforms is expected to grow in near future. Growing adoption of software solutions during research studies, high R&D expenditure by pharmaceutical companies, favorable government grants to support clinical trials, and a widening base of potential customers are some of the key factors contributing to market growth.

Electronic Clinical Outcome Assessment Solutions Market Report Highlights

  • Web & Cloud-based solutions are anticipated to grow at an exponential rate owing to integrated features that include flexibility, high accessibility, negligible handling costs, and easy data backup. The added advantage of remote access to information also contributes to segment growth.

  • Contract research organizations dominated the electronic clinical outcome assessment solutions market as major pharmaceutical companies are focused on reducing expenditure on clinical trials.

  • Asia Pacific market is expected to show the fastest growth over the forecast period owing to the increasing clinical research activities by end-users such as CROs and biopharmaceutical companies.

Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Electronic Clinical Outcome Assessment Solutions Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Penetration & Growth Prospect Mapping, 2021
3.3 Electronic Clinical Outcome Assessment Solutions Market Dynamics
3.3.1 Market Driver Analysis
3.3.2 Market Restraint Analysis
3.4 Electronic Clinical Outcome Assessment Solutions Market Analysis Tools: Porters
3.4.1 Supplier Power
3.4.2. Buyer Power
3.4.3. Substitution Threat
3.4.4. Threat Of New Entrants
3.4.5. Competitive Rivalry
3.5 Electronic Clinical Outcome Assessment Solutions Industry Analysis-Pest (Political & Legal, Economic, Social, and Technological)
3.5.1 Political/Legal Landscape
3.5.2 Economic Landscape
3.5.3 Social Landscape
3.5.4 Technology Landscape

Chapter 4. Covid-19 Impact Analysis
4.1 Covid-19 Prevalence Analysis
4.2 Current Impact & Future Scenario
4.3. Impact On Market Players

Chapter 5. Electronic Clinical Outcome Assessment Solutions Market: Segment Analysis, by Delivery Mode 2017-2030 (USD Million)
5.1 Delivery Mode Market Share Analysis, 2021 & 2030
5.2 Electronic Clinical Outcome Assessment Solutions Market, by Delivery Mode, 2017 To 2030
5.3 Web & Cloud-Based
5.3.1 Web & Cloud-Based Market 2017-2030 (USD Million)
5.4 On-Premise
5.4.1 On-Premise Market 2017-2030 (USD Million)

Chapter 6. Electronic Clinical Outcome Assessment Solutions Market: Segment Analysis, by End User 2017-2030 (USD Million)
6.1 End User Market Share Analysis, 2021 & 2030
6.2 Electronic Clinical Outcome Assessment Solutions Market, by End User, 2017 To 2030
6.3 Pharmaceutical and Biotechnology Firms
6.3.1 Pharmaceutical and Biotechnology Firms Market 2017-2030 (USD Million)
6.4 Medical Device Companies
6.4.1 Medical Device Companies Market 2017-2030 (USD Million)
6.5 Hospitals/Healthcare Providers
6.5.1 Hospitals/Healthcare Providers Market 2017-2030 (USD Million)
6.6 Cros
6.6.1 Cros Market 2017-2030 (USD Million)
6.7 Others
6.7.1 Others Market 2017-2030 (USD Million)

Chapter 7. Electronic Clinical Outcome Assessment Solutions Market: Regional Market Analysis 2017-2030 (Usd Million)

Chapter 8. Electronic Clinical Outcome Assessment Solutions Market-Competitive Analysis
8.1 Market Participant Categorization
8.1.1. Company Market Position Analysis
8.1.2. Synergy Analysis: Major Deals & Strategic Alliances
8.1.3. Market Leaders
8.1.4. Innovators
8.2. List Of Key Companies

Chapter 9. Electronic Clinical Outcome Assessment Solutions Market-Company Profiles
9.1 Ibm
9.1.1 Company Overview
9.1.2 Financial Performance
9.1.3 Product Benchmarking
9.1.4 Strategic Initiatives
9.2 Medidata Solutions, Inc.
9.2.1 Company Overview
9.2.2 Financial Performance
9.2.3 Product Benchmarking
9.2.4 Strategic Initiatives
9.3 Iqvia Inc.
9.3.1 Company Overview
9.3.2 Financial Performance
9.3.3 Product Benchmarking
9.3.4 Strategic Initiatives
9.4 Clario
9.4.1 Company Overview
9.4.2 Financial Performance
9.4.3 Product Benchmarking
9.4.4 Strategic Initiatives
9.5 Arisglobal
9.5.1 Company Overview
9.5.2 Financial Performance
9.5.3 Product Benchmarking
9.5.4 Strategic Initiatives
9.6 Signant Health
9.6.1 Company Overview
9.6.2 Financial Performance
9.6.3 Product Benchmarking
9.6.4 Strategic Initiatives
9.7 Transperfect
9.7.1 Company Overview
9.7.2 Financial Performance
9.7.3 Product Benchmarking
9.7.4 Strategic Initiatives
9.8 Cloudbyz
9.8.1 Company Overview
9.8.2 Financial Performance
9.8.3 Product Benchmarking
9.8.4 Strategic Initiatives
9.9 Climedo Health Gmbh
9.9.1 Company Overview
9.9.2 Financial Performance
9.9.3 Product Benchmarking
9.9.4 Strategic Initiatives
9.10 Clincapture
9.10.1 Company Overview
9.10.2 Financial Performance
9.10.3 Product Benchmarking
9.10.4 Strategic Initiatives

For more information about this report visit https://www.researchandmarkets.com/r/sz8oo2

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

 

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

 

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 

Cision
Cision

View original content:https://www.prnewswire.com/news-releases/the-worldwide-electronic-clinical-outcome-assessment-solutions-industry-is-expected-to-reach-4-12-billion-by-2030--301563966.html

SOURCE Research and Markets